Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 44)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A SLXP: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SALIX PHARMACEUTICALS LTD 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: SALIX PHARMACEUT -- SLXP 1 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SALIX PHARMACEUTICALS LTD including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ACUR , AMLN , LCI , MTXX , NRGN , SLXP -- DRUGS 3 $4 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SALIX PHARMACEUTICALS LTD 5 $25 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
12-Nov-09 Caris & Company James Molloy SLXP-3Q In-Line, Reiterate 1*/Buy 9 $25 View Abstract
10-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 30 $75 View Abstract
10-Nov-09 Thomson StreetEvents N/A SLXP - Event Transcript of Salix Pharmaceuticals, Inc. conference call, Nov. 09, 2009 / 5:00pm ET 16 $75 View Abstract
10-Nov-09 Thomson StreetEvents N/A SLXP - Event Brief of Salix Pharmaceuticals, Inc. conference call, Nov. 09, 2009 / 5:00pm ET 17 $75 View Abstract
10-Nov-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Q3 results a non-event as 2010-11 launches the key 7 $25 View Abstract
3-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
3-Nov-09 Roth Capital Partners, Inc. Scott R. Henry CFA Physician audience appears bullish on rifaximin (Xifaxan) to treat HE 4 $10 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 20 $50 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino ACG meeting highlights positive sentiment for Xifaxan to treat IBS 7 $25 View Abstract
22-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 31)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A SLXP: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SALIX PHARMACEUTICALS LTD 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: SALIX PHARMACEUT -- SLXP 1 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SALIX PHARMACEUTICALS LTD including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ACUR , AMLN , LCI , MTXX , NRGN , SLXP -- DRUGS 3 $4 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: SALIX PHARMACEUTICALS LTD 5 $25 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.